Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico · Delayed Price · Currency is MXN 100.00
0.00 (0.00%)
At close: Oct 3, 2025
Recursion Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | -649.13 | -463.66 | -328.07 | -239.48 | -186.48 | -87.01 | Upgrade |
Depreciation & Amortization | 63.33 | 36.49 | 24.4 | 11.76 | 8.41 | 3.94 | Upgrade |
Stock-Based Compensation | 111.25 | 81.69 | 53.5 | 27.91 | 14.84 | 4.29 | Upgrade |
Other Adjustments | 45.98 | 24.31 | 12.64 | 11.37 | 4.92 | 2.54 | Upgrade |
Change in Receivables | 24.48 | -6.07 | -7.76 | -0 | -5.38 | -1.12 | Upgrade |
Changes in Accounts Payable | 5.46 | 6.44 | -0.99 | 1.77 | 1.75 | -0.19 | Upgrade |
Changes in Accrued Expenses | 3.42 | 5.26 | 9.42 | -0.05 | 13.33 | 5.47 | Upgrade |
Changes in Unearned Revenue | -25.13 | -28.04 | -41.08 | 110.32 | -10 | 26.67 | Upgrade |
Changes in Other Operating Activities | -20.07 | -15.58 | -9.86 | -7.11 | - | - | Upgrade |
Operating Cash Flow | -383.03 | -359.17 | -287.78 | -83.52 | -158.61 | -45.4 | Upgrade |
Capital Expenditures | -10.84 | -13.7 | -11.96 | -37.06 | -39.8 | -5.83 | Upgrade |
Purchases of Intangible Assets | - | -3.35 | -0.6 | -0.3 | - | -0.9 | Upgrade |
Purchases of Investments | - | - | - | - | -301.14 | - | Upgrade |
Proceeds from Sale of Investments | - | - | 0.48 | 230.61 | 69.19 | - | Upgrade |
Payments for Business Acquisitions | - | 277.1 | 1.84 | - | - | -2.6 | Upgrade |
Other Investing Activities | - | - | - | - | - | 0.6 | Upgrade |
Investing Cash Flow | 257.82 | 260.06 | -10.23 | 193.25 | -271.74 | -8.74 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 6.4 | Upgrade |
Long-Term Debt Repaid | -8.52 | -4.44 | -0.77 | -0.09 | -12.8 | -0.08 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -8.52 | -4.44 | -0.77 | -0.09 | -12.8 | 6.32 | Upgrade |
Issuance of Common Stock | 176.81 | 308.56 | 140.9 | 154.44 | 471.34 | 0.68 | Upgrade |
Net Common Stock Issued (Repurchased) | 176.81 | 308.56 | 140.9 | 154.44 | 471.34 | 0.68 | Upgrade |
Issuance of Preferred Stock | - | - | - | - | - | 239.13 | Upgrade |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 239.13 | Upgrade |
Financing Cash Flow | 165.29 | 304.12 | 140.13 | 154.35 | 458.54 | 246.14 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 11.02 | -3.41 | 0.19 | -0.31 | - | - | Upgrade |
Net Cash Flow | 51.09 | 201.6 | -157.69 | 263.76 | 28.18 | 192 | Upgrade |
Beginning Cash & Cash Equivalents | 482.75 | 401.43 | 559.11 | 295.35 | 267.17 | 75.17 | Upgrade |
Ending Cash & Cash Equivalents | 533.85 | 603.02 | 401.43 | 559.11 | 295.35 | 267.17 | Upgrade |
Free Cash Flow | -393.87 | -372.87 | -299.74 | -120.58 | -198.41 | -51.23 | Upgrade |
FCF Margin | -609.75% | -633.71% | -672.43% | -302.65% | -1949.42% | -1293.03% | Upgrade |
Free Cash Flow Per Share | -1.23 | -1.36 | -1.44 | -0.69 | -1.58 | -2.35 | Upgrade |
Levered Free Cash Flow | -641.49 | -477.23 | -358.89 | -159.95 | -225.6 | -50.62 | Upgrade |
Unlevered Free Cash Flow | -633.57 | -486.97 | -375.83 | -166.11 | -209.1 | -54.55 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.